At meeting held on 21 July 2014
Bafna Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 21 July 2014, have decided for selling majority stake of branded generic business to Strides Arcolab and in this connection entered into agreement(s) with Strides Arcolab on 21 July 2014.Powered by Capital Market - Live News
